Medicine and Dentistry
Patient
90%
Chronic Pulmonary Aspergillosis
81%
Therapeutic Procedure
34%
Inpatient
26%
Bloodstream Infection
18%
Diagnosis
18%
Aspergillus
17%
Diseases
15%
Lung
14%
Tuberculosis
14%
Bacteremia
13%
Effusion
11%
Histoplasmosis
11%
Klebsiella pneumoniae
11%
Staphylococcus Aureus
11%
Lung Aspergillosis
11%
Anti-biotics
10%
Antifungal Therapy
10%
Infection
9%
Odds Ratio
9%
Hospital
9%
Gene
8%
Follow up
8%
Outpatient
8%
Gram Positive Infection
8%
Ethidium Bromide
8%
Diagnostics
8%
Surgery
8%
Bacterial Infection
7%
Daptomycin
7%
Prevalence
7%
Serum
7%
C Reactive Protein
7%
Vaccine
7%
Triazole
7%
Symptom
7%
Pseudomonas aeruginosa
7%
Syndrome
7%
Age
7%
Pneumonia
7%
Carbapenem Derivative
7%
Cohort Effect
7%
Association
6%
Gamma Interferon
6%
Allergic Bronchopulmonary Aspergillosis
6%
Assessment
6%
Clinical Significance
6%
Posaconazole
6%
Multidrug Resistance
6%
Drug
6%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Aspergillosis
100%
Aspergillus
35%
Bloodstream Infection
24%
Tuberculosis
20%
Posaconazole
19%
Infection
18%
Drug
17%
Klebsiella pneumoniae
17%
Enterobacteriaceae
17%
Metallo Beta Lactamase
17%
Adverse Event
14%
Carbapenem
14%
Bacteremia
13%
Voriconazole
13%
Therapeutic Drug Monitoring
13%
Antigen
11%
Antibody
11%
Itraconazole
11%
Diseases
11%
Prevalence
10%
Toxicity
10%
Pneumonia
10%
Observational Study
9%
Prospective Study
9%
Antifungal
8%
Aspergillosis
8%
Carbapenem Derivative
8%
Chemotherapy
8%
Antifungal Agent
8%
Histoplasmosis
8%
Mortality
8%
Gram Positive Infection
8%
Lung Tuberculosis
7%
HIV
7%
Bacterial Infection
7%
Daptomycin
7%
Pharmacokinetics
7%
Paclitaxel
7%
Chronic Obstructive Lung Disease
7%
Isavuconazole
7%
Bacterium
7%
Incidence
7%
Organisms
7%
Infectious Agent
6%
Gamma Interferon
6%
Escherichia coli
6%
Complication
6%
Quinolone Derivative
6%
Gram Positive Bacterium
6%
Antiinfective Agent
5%
Immunology and Microbiology
Aspergillus
30%
Monospecific Antibody
17%
Immunodeficiency
12%
Gene Expression
11%
Klebsiella pneumoniae
11%
Staphylococcus Aureus
11%
Minimum Inhibitory Concentration
11%
Prevalence
8%
Integron
8%
Interferon Gamma
8%
Allergic Bronchopulmonary Aspergillosis
8%
Lung
7%
C-Reactive Protein
7%
Pseudomonas aeruginosa
7%
Immunotherapy
7%
CD19
7%
Incidence
7%
Enterobacteriaceae
7%
Association
6%
Gene
6%
Life
6%
Escherichia coli
6%
Screening
6%
Species
6%
Mycobiome
5%
Procalcitonin
5%
Serotype
5%
Lymphopenia
5%
Antigen
5%
Antifungal Susceptibility
5%
Squamous Cell
5%
Western Blot
5%
Computer Model
5%
Genetic Correlation
5%
Antibody Screening
5%
Infectious Agent
5%
Multidrug Resistance
5%